On March 12, 2026, NovaBay Pharmaceuticals, Inc. filed a second amended and restated certificate of incorporation, removing the prohibition against stockholder action by written consent and increasing authorized shares to 5 billion. Stockholders approved key proposals at a special meeting.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.